Lupin receives FDA OK for generic TrokendiTopiramate extended-release capsules are indicated for the treatment of partial-onset or primary generalized tonic-clonic seizures in certain patients. Endo debuts generic Thiola ECTiopronin is used in combination with high fluid intake, alkali and dietary changes to help prevent the formation of kidney stones. Alembic receives tentative OK from FDA for generic Uptravi Selexipag is indicated for the treatment of pulmonary arterial hypertension to delay disease progression and reduce the risk of hospitalization. Samsung Bioepis releases Q3 2024 U.S. biosimilar market report As of June 2024, the FDA has approved a total of 57 biosimilars across 17 unique biological molecules; of the 57 approvals, 39 biosimilars have launched in the U.S. market. Hikma launches sodium acetate injection Sodium acetate injection had a market value of roughly $26 million in the 12 months ending May 2024, per IQVIA. Amneal intros Focinvez Focinvez 150 mg/50 mL single dose vial is an anti-nausea agent for emetogenic chemotherapy. Arunesh Verma joins Fresenius Kabi USA as president Verma succeeds John Ducker who will retire after 35 years with the company. Fresenius debuts subcutaneous formulation of biosimilar Tyenne Tyenne is an FDA-approved tocilizumab biosimilar that is available in both intravenous and subcutaneous formulations. Just – Evotec Biologics expands tech partnership for biosimilars with Sandoz This expanded partnership solidifies Just – Evotec Biologics’ commitment to providing long-term commercial supply of biosimilars to Sandoz. Yaral Pharma becomes exclusive supplier of authorized generic levothyroxine sodium capsules Levothyroxine Sodium Capsules are used to treat hypothyroidism. First Previous 16 17 18 19 20 Next Last
